ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,068.19
0.44%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Zivo Bioscience Inc (ZIVO)

  7. Zivo Bioscience Inc (ZIVO) Noticias

ZIVO

Zivo Bioscience (ZIVO)

Zivo Bioscience Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ZIVO
FechaHoraFuenteTítuloSímboloCompañía
26/04/202412:36Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ZIVOZivo Bioscience Inc
26/04/202407:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZIVOZivo Bioscience Inc
26/04/202407:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ZIVOZivo Bioscience Inc
09/04/202410:49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
14/03/202408:16Edgar (US Regulatory)Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
15/02/202415:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
15/02/202407:54Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:ZIVOZivo Bioscience Inc
07/02/202415:54Business WireZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge StudyNASDAQ:ZIVOZivo Bioscience Inc
29/01/202407:00Business WireZIVO Bioscience Announces Uplisting to OTCQB MarketNASDAQ:ZIVOZivo Bioscience Inc
22/01/202416:15Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ZIVOZivo Bioscience Inc
04/01/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
13/11/202315:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZIVOZivo Bioscience Inc
03/11/202309:18Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
30/10/202307:30Business WireZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler ChickensNASDAQ:ZIVOZivo Bioscience Inc
26/10/202307:30Business WireZIVO Bioscience Announces Reverse Stock SplitNASDAQ:ZIVOZivo Bioscience Inc
04/10/202316:08Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ZIVOZivo Bioscience Inc
03/10/202307:30GlobeNewswire Inc.ZIVO Bioscience to Present at the Dawson James Small Cap Growth ConferenceNASDAQ:ZIVOZivo Bioscience Inc
21/09/202308:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:ZIVOZivo Bioscience Inc
19/09/202315:15Business WireTrial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler ChickensNASDAQ:ZIVOZivo Bioscience Inc
16/08/202314:00Business WireZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 MonthsNASDAQ:ZIVOZivo Bioscience Inc
03/08/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZIVOZivo Bioscience Inc
03/08/202315:34Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ZIVOZivo Bioscience Inc
26/07/202315:15Business WireZIVO Commences Sales of its Proprietary Algal Biomass as Human FoodNASDAQ:ZIVOZivo Bioscience Inc
17/07/202315:07Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ZIVOZivo Bioscience Inc
05/07/202306:21Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ZIVOZivo Bioscience Inc
30/06/202312:55Business WireZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-MarketNASDAQ:ZIVOZivo Bioscience Inc
28/06/202315:11Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:ZIVOZivo Bioscience Inc
28/06/202315:10Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ZIVOZivo Bioscience Inc
16/06/202305:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIVOZivo Bioscience Inc
30/05/202307:45Business WireZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food IngredientNASDAQ:ZIVOZivo Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:ZIVO

Su Consulta Reciente

USOTC
RHHBY
Roche (QX)
USI
USTECH100
US Tech 100
NYSE
AXP
American Express
AMEX
SPY
SPDR S&P 500
NYSE
VZ
Verizon Communications
PM
XAUUSD
Gold vs US Dollar
NASDAQ
TSLA
Tesla
NYSE
DIS
Walt Disney
NASDAQ
AMZN
Amazon.com
CCOM
US30
US 30
NASDAQ
GOOGL
Alphabet
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
NVDA
NVIDIA
SPI
SP500
S&P 500
USOTC
BASFY
BASF (QX)
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados